ADSS1
Basic information
Region (hg38): 14:104724174-104747325
Previous symbols: [ "ADSSL1" ]
Links
Phenotypes
GenCC
Source:
- myopathy, distal, 5 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Myopathy, distal, 5 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal | 26506222; 28268051; 32331917; 32646962 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (14 variants)
- Myopathy, distal, 5 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADSS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 83 | 92 | ||||
missense | 177 | 182 | ||||
nonsense | 5 | |||||
start loss | 7 | |||||
frameshift | 13 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 10 | |||||
splice region | 6 | 16 | 2 | 24 | ||
non coding | 53 | 62 | ||||
Total | 14 | 9 | 191 | 137 | 22 |
Highest pathogenic variant AF is 0.0000853
Variants in ADSS1
This is a list of pathogenic ClinVar variants found in the ADSS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-104724300-G-GC | Myopathy, distal, 5 | Uncertain significance (Jan 01, 2019) | ||
14-104724307-G-A | Inborn genetic diseases | Uncertain significance (Nov 03, 2023) | ||
14-104724323-A-G | Inborn genetic diseases | Uncertain significance (Jan 23, 2024) | ||
14-104724348-G-A | Likely benign (Nov 01, 2022) | |||
14-104724362-C-A | Inborn genetic diseases | Uncertain significance (Apr 23, 2024) | ||
14-104724367-G-C | Inborn genetic diseases | Uncertain significance (Jun 11, 2024) | ||
14-104724371-C-T | Inborn genetic diseases | Uncertain significance (Sep 29, 2023) | ||
14-104724373-G-A | Inborn genetic diseases | Uncertain significance (Nov 28, 2023) | ||
14-104724373-G-C | Inborn genetic diseases | Uncertain significance (Dec 07, 2021) | ||
14-104724399-C-G | Inborn genetic diseases | Uncertain significance (Sep 14, 2022) | ||
14-104724434-C-T | Inborn genetic diseases | Uncertain significance (May 29, 2024) | ||
14-104724445-A-G | Inborn genetic diseases | Uncertain significance (Apr 12, 2022) | ||
14-104724461-AGGTGCGGGCTGGGGCGCCG-A | not specified | Uncertain significance (Apr 04, 2024) | ||
14-104729867-GTCGTGGGGAGGAGCGTGGCGTCGGCA-G | Uncertain significance (Feb 21, 2022) | |||
14-104729869-CGTGGGGAGGAGCGTGGCGTCGGCATG-C | Uncertain significance (Oct 17, 2022) | |||
14-104729890-G-A | ADSS1-related disorder | Likely benign (Sep 03, 2020) | ||
14-104729893-A-C | ADSS1-related disorder | Benign (Feb 01, 2024) | ||
14-104729893-A-G | Uncertain significance (Jan 19, 2024) | |||
14-104729893-ATG-GTC | Uncertain significance (Aug 08, 2022) | |||
14-104729895-G-C | Uncertain significance (Jan 19, 2024) | |||
14-104729895-G-T | Uncertain significance (Dec 02, 2022) | |||
14-104729897-T-G | Uncertain significance (Nov 05, 2021) | |||
14-104729898-G-A | Myopathy, distal, 5 | Benign (Feb 01, 2024) | ||
14-104729905-A-G | Uncertain significance (Aug 05, 2022) | |||
14-104729914-G-A | Uncertain significance (Apr 10, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ADSS1 | protein_coding | protein_coding | ENST00000332972 | 13 | 23140 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.82e-7 | 0.982 | 125578 | 2 | 168 | 125748 | 0.000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0328 | 306 | 304 | 1.01 | 0.0000184 | 3206 |
Missense in Polyphen | 148 | 139.96 | 1.0574 | 1315 | ||
Synonymous | 0.811 | 117 | 129 | 0.909 | 0.00000874 | 1007 |
Loss of Function | 2.20 | 15 | 27.4 | 0.547 | 0.00000145 | 294 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00205 | 0.00205 |
Ashkenazi Jewish | 0.000994 | 0.000993 |
East Asian | 0.00131 | 0.00131 |
Finnish | 0.0000925 | 0.0000924 |
European (Non-Finnish) | 0.000469 | 0.000457 |
Middle Eastern | 0.00131 | 0.00131 |
South Asian | 0.000557 | 0.000523 |
Other | 0.000491 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the purine nucleotide cycle (PNC), which interconverts IMP and AMP to regulate the nucleotide levels in various tissues, and which contributes to glycolysis and ammoniagenesis. Catalyzes the first committed step in the biosynthesis of AMP from IMP. {ECO:0000269|PubMed:26506222}.;
- Pathway
- Alanine, aspartate and glutamate metabolism - Homo sapiens (human);Purine metabolism - Homo sapiens (human);Hypoacetylaspartia;Aspartate Metabolism;Canavan Disease;adenosine ribonucleotides <i>de novo</i> biosynthesis;Metabolism of nucleotides;Alanine Aspartate Asparagine metabolism;Metabolism;Nucleobase biosynthesis;Purine nucleotides nucleosides metabolism;superpathway of purine nucleotide salvage;Purine ribonucleoside monophosphate biosynthesis;purine nucleotides <i>de novo</i> biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.155
Intolerance Scores
- loftool
- 0.875
- rvis_EVS
- -0.02
- rvis_percentile_EVS
- 52.25
Haploinsufficiency Scores
- pHI
- 0.257
- hipred
- Y
- hipred_score
- 0.542
- ghis
- 0.610
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.683
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Adssl1
- Phenotype
Zebrafish Information Network
- Gene name
- adssl1
- Affected structure
- skeletal muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- apoptotic
Gene ontology
- Biological process
- immune system process;AMP biosynthetic process;aspartate metabolic process;glutamine metabolic process;purine ribonucleoside monophosphate biosynthetic process;response to muscle activity;cellular response to drug;response to starvation;'de novo' AMP biosynthetic process;IMP metabolic process;cellular response to electrical stimulus
- Cellular component
- cytoplasm;cytosol
- Molecular function
- magnesium ion binding;GTPase activity;adenylosuccinate synthase activity;GTP binding;phosphate ion binding;protein homodimerization activity;actin filament binding